NITI Aayog Says Patents Not Important, But Indian Govt at WTO Has Been Saying the Opposite

In this episode of COVID Watch, Professor Satyajit Rath and Prabir Purkayastha discuss the issue for patents for COVID vaccines and drugs in India.

In this episode of COVID Watch, Professor Satyajit Rath and Prabir Purkayastha discuss the issue for patents for COVID vaccines and drugs in India. They talk about how the Indian govt has been slow in providing compulsory licensing for manufacturing of drugs and vaccines for COVID in the country, while proposing a waiver on patents at the WTO. They also discuss the arbitrary pricing policy of the govt which has left these essentials inaccessible for many.